Objective This study investigates the role of miR-144-5p in doxorubicin(DOX)-induced heart failure and explores its potential mechanisms by targeting ACSM1 and inhibiting lipid peroxidation.Methods Bioinformatics anal...Objective This study investigates the role of miR-144-5p in doxorubicin(DOX)-induced heart failure and explores its potential mechanisms by targeting ACSM1 and inhibiting lipid peroxidation.Methods Bioinformatics analysis was performed using the gene expression omnibus dataset GSE136547 to identify differentially expressed miRNAs in heart failure.DOX-induced in vitro and in vivo heart failure models were used to study the effects of miR-144-5p on cardiomyocyte viability,apoptosis,and lipid peroxidation.The targeting relationship between miR-144-5p and ACSM1 was verified using dual-luciferase reporter assays.Cardiac function was assessed by echocardiography,and biochemical markers of heart failure were measured using ELISA.The GO and KEGG enrichment analyses of ACSM1 were performed via the bioinformatic tools GeneMANIA and STRING.Results miR-144-5p was significantly upregulated in DOX-treated cardiomyocytes and mouse hearts.Inhibition of miR-144-5p attenuated DOX-induced cardiomyocyte apoptosis,lipid peroxidation,and cardiac dysfunction.ACSM1 was identified as a direct target of miR-144-5p,and its expression was downregulated by DOX.Silencing ACSM1 abolished the protective effects of the miR-144-5p inhibitor on the viability,apoptosis,and lipid peroxidation of cardiomyocytes.Furthermore,miR-144-5p inhibition improved cardiac function in DOX-treated mice,as evidenced by reduced left ventricular dysfunction and decreased levels of heart failure markers(BNP,LDH,Ang II,and ALD).Conclusions Our findings demonstrate that inhibiting miR-144-5p alleviates DOX-induced heart failure by targeting ACSM1 and suppressing lipid peroxidation.The miR-144-5p/ACSM1 axis may represent a novel therapeutic target for heart failure.Future studies should focus on further elucidating the mechanisms underlying this axis and exploring its potential clinical applications.展开更多
基金supported by Chongqing Science and Health Joint Medical Research Project(No.2023MSXM081)2023 Key Disciplines on Public Health Construction in Chongqing.
文摘Objective This study investigates the role of miR-144-5p in doxorubicin(DOX)-induced heart failure and explores its potential mechanisms by targeting ACSM1 and inhibiting lipid peroxidation.Methods Bioinformatics analysis was performed using the gene expression omnibus dataset GSE136547 to identify differentially expressed miRNAs in heart failure.DOX-induced in vitro and in vivo heart failure models were used to study the effects of miR-144-5p on cardiomyocyte viability,apoptosis,and lipid peroxidation.The targeting relationship between miR-144-5p and ACSM1 was verified using dual-luciferase reporter assays.Cardiac function was assessed by echocardiography,and biochemical markers of heart failure were measured using ELISA.The GO and KEGG enrichment analyses of ACSM1 were performed via the bioinformatic tools GeneMANIA and STRING.Results miR-144-5p was significantly upregulated in DOX-treated cardiomyocytes and mouse hearts.Inhibition of miR-144-5p attenuated DOX-induced cardiomyocyte apoptosis,lipid peroxidation,and cardiac dysfunction.ACSM1 was identified as a direct target of miR-144-5p,and its expression was downregulated by DOX.Silencing ACSM1 abolished the protective effects of the miR-144-5p inhibitor on the viability,apoptosis,and lipid peroxidation of cardiomyocytes.Furthermore,miR-144-5p inhibition improved cardiac function in DOX-treated mice,as evidenced by reduced left ventricular dysfunction and decreased levels of heart failure markers(BNP,LDH,Ang II,and ALD).Conclusions Our findings demonstrate that inhibiting miR-144-5p alleviates DOX-induced heart failure by targeting ACSM1 and suppressing lipid peroxidation.The miR-144-5p/ACSM1 axis may represent a novel therapeutic target for heart failure.Future studies should focus on further elucidating the mechanisms underlying this axis and exploring its potential clinical applications.
